Search through all our worldwide HIV and AIDS news and features, using the topics below to filter your results by subjects including HIV treatment, transmission and prevention, and hepatitis and TB co-infections.

HIV treatment news

Show

From To
Gilead abandons research on salvage drug

Gilead Sciences today announced that it has decided to abandon its research programme to develop the experimental nucleoside analogue amdoxovir (DAPD). Rights to develop the

Published
28 January 2004
By
Keith Alcorn
New formulation of nelfinavir clears key hurdle on road to EU approval

A new formulation of the protease inhibitor nelfinavir (Viracept), that reduces the drug’s daily pill burden by 60% has received a positive opinion from the

Published
28 January 2004
By
Michael Carter
Once-daily topical tablet as effective as systemic drugs for oral thrush

A daily slow release topical oral treatment is as effective a treatment for oropharyngeal candida as systemic anti-fungal therapy in severely immunosuppressed individuals according to

Published
27 January 2004
By
Michael Carter
Are WHO and Global Fund supporting sub-standard malaria treatment?

“At least tens of thousands of children die every year” because the World Health Organisation and the Global Fund for AIDS, Tuberculosis, and Malaria (GFATM)

Published
27 January 2004
By
Theo Smart
Atazanavir shown to boost amprenavir levels

Even before the 400% US price rise of ritonavir announced last month by Abbott, and the growing movement to boycott Abbott products both in US

Published
26 January 2004
By
Edwin J. Bernard
French HIV-2 cohort study: treat only when plasma viral load can be measured.

HIV–2 is a genetically distinct virus from HIV-1, the latter of which is by far the most common form of HIV worldwide. HIV-2 is found

Published
26 January 2004
By
Edwin J. Bernard
Ritonavir price increase: Abbott no longer welcome in our offices, say 34 leading HIV docs

US HIV clinicians are being asked to join an “immediate and formal” boycott of the pharmaceutical company Abbott Laboratories by many of the US's leading

Published
26 January 2004
By
Michael Carter
Russian health policies and inaction risk 'super-resistant' TB warn MSF

Inaction by Russian health authorities could mean that super-resistant strains of tuberculosis (TB) emerge in the country, according to a letter from Medecins sans Frontiieres

Published
23 January 2004
By
Michael Carter
Poor drug supply causing treatment problems in South Africa, Nigeria

Problems with drug supply of antiretrovirals have come to the surface in both Nigeria and South Africa in the past few weeks as the realities

Published
21 January 2004
By
Keith Alcorn
Leading AIDS experts criticise major US vaccine trial

US scientists and AIDS advocates yesterday called into question the US National Institutes of Health decision to proceed with trials of a controversial vaccine strategy

Published
16 January 2004
By
Keith Alcorn

Filter by country

Community Consensus Statement on Access to HIV Treatment and its Use for Prevention

Together, we can make it happen

We can end HIV soon if people have equal access to HIV drugs as treatment and as PrEP, and have free choice over whether to take them.

Launched today, the Community Consensus Statement is a basic set of principles aimed at making sure that happens.

The Community Consensus Statement is a joint initiative of AVAC, EATG, MSMGF, GNP+, HIV i-Base, the International HIV/AIDS Alliance, ITPC and NAM/aidsmap
close

This content was checked for accuracy at the time it was written. It may have been superseded by more recent developments. NAM recommends checking whether this is the most current information when making decisions that may affect your health.

NAM’s information is intended to support, rather than replace, consultation with a healthcare professional. Talk to your doctor or another member of your healthcare team for advice tailored to your situation.